Literature DB >> 24788181

A solid-phase assay for studying direct binding of progranulin to TNFR and progranulin antagonism of TNF/TNFR interactions.

Qingyun Tian1, Shuai Zhao, Chuanju Liu.   

Abstract

The discovery that TNF receptors (TNFR) serve as the binding receptors for progranulin (PGRN) reveals the significant role of PGRN in inflammatory and autoimmune diseases, including inflammatory arthritis. Herein we describe a simple, antibody-free analytical assay, i.e., a biotin-based solid-phase binding assay, to examine the direct interaction of PGRN/TNFR and the PGRN inhibition of TNF/TNFR interactions. Briefly, a 96-well high-binding microplate is first coated with the first protein (protein A), and after blocking, the coated microplate is incubated with the biotin-labeled second protein (protein B) in the absence or presence of the third protein (protein C). Finally the streptavidin conjugated with a detecting enzyme is added, followed by a signal measurement. Also discussed in this chapter are the advantages of the strategy, key elements to obtain reliable results, and discrepancies among various PGRN proteins in view of the binding activity with TNFR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24788181      PMCID: PMC4406480          DOI: 10.1007/978-1-4939-0669-7_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  29 in total

1.  Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors.

Authors:  Sarah Knox; Catherine Merry; Sally Stringer; James Melrose; John Whitelock
Journal:  J Biol Chem       Date:  2002-02-14       Impact factor: 5.157

2.  Cellular localization of gene expression for progranulin.

Authors:  R Daniel; Z He; K P Carmichael; J Halper; A Bateman
Journal:  J Histochem Cytochem       Date:  2000-07       Impact factor: 2.479

3.  Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo.

Authors:  Z He; A Bateman
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

4.  Perlecan from human epithelial cells is a hybrid heparan/chondroitin/keratan sulfate proteoglycan.

Authors:  S Knox; A J Fosang; K Last; J Melrose; J Whitelock
Journal:  FEBS Lett       Date:  2005-09-12       Impact factor: 4.124

5.  Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells.

Authors:  J M Whitelock; L D Graham; J Melrose; A D Murdoch; R V Iozzo; P A Underwood
Journal:  Matrix Biol       Date:  1999-04       Impact factor: 11.583

6.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.

Authors:  Marc Cruts; Ilse Gijselinck; Julie van der Zee; Sebastiaan Engelborghs; Hans Wils; Daniel Pirici; Rosa Rademakers; Rik Vandenberghe; Bart Dermaut; Jean-Jacques Martin; Cornelia van Duijn; Karin Peeters; Raf Sciot; Patrick Santens; Tim De Pooter; Maria Mattheijssens; Marleen Van den Broeck; Ivy Cuijt; Krist'l Vennekens; Peter P De Deyn; Samir Kumar-Singh; Christine Van Broeckhoven
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

Review 7.  Autocrine growth factor revisited: PC-cell-derived growth factor (progranulin), a critical player in breast cancer tumorigenesis.

Authors:  Ginette Serrero
Journal:  Biochem Biophys Res Commun       Date:  2003-08-29       Impact factor: 3.575

8.  A microtiter assay for quantifying protein-protein interactions associated with cell-cell adhesion.

Authors:  Nicholas A Graham; Melissa D Pope; Tharathorn Rimchala; Beijing K Huang; Anand R Asthagiri
Journal:  J Biomol Screen       Date:  2007-05-16

9.  A novel interaction between perlecan protein core and progranulin: potential effects on tumor growth.

Authors:  Eva M Gonzalez; Maurizio Mongiat; Simon J Slater; Raffaele Baffa; Renato V Iozzo
Journal:  J Biol Chem       Date:  2003-08-04       Impact factor: 5.157

10.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17.

Authors:  Matt Baker; Ian R Mackenzie; Stuart M Pickering-Brown; Jennifer Gass; Rosa Rademakers; Caroline Lindholm; Julie Snowden; Jennifer Adamson; A Dessa Sadovnick; Sara Rollinson; Ashley Cannon; Emily Dwosh; David Neary; Stacey Melquist; Anna Richardson; Dennis Dickson; Zdenek Berger; Jason Eriksen; Todd Robinson; Cynthia Zehr; Chad A Dickey; Richard Crook; Eileen McGowan; David Mann; Bradley Boeve; Howard Feldman; Mike Hutton
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

View more
  11 in total

1.  PGRN induces impaired insulin sensitivity and defective autophagy in hepatic insulin resistance.

Authors:  Jiali Liu; Huixia Li; Bo Zhou; Lin Xu; Xiaomin Kang; Wei Yang; Shufang Wu; Hongzhi Sun
Journal:  Mol Endocrinol       Date:  2015-02-09

2.  Administration of progranulin (PGRN) triggers ER stress and impairs insulin sensitivity via PERK-eIF2α-dependent manner.

Authors:  Huixia Li; Bo Zhou; Jiali Liu; Fang Li; Yulong Li; Xiaomin Kang; Hongzhi Sun; Shufang Wu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 3.  Progranulin: A conductor of receptors orchestra, a chaperone of lysosomal enzymes and a therapeutic target for multiple diseases.

Authors:  Yazhou Cui; Aubryanna Hettinghouse; Chuan-Ju Liu
Journal:  Cytokine Growth Factor Rev       Date:  2019-01-30       Impact factor: 7.638

4.  Progranulin associates with hexosaminidase A and ameliorates GM2 ganglioside accumulation and lysosomal storage in Tay-Sachs disease.

Authors:  Yuehong Chen; Jinlong Jian; Aubryanna Hettinghouse; Xueheng Zhao; Kenneth D R Setchell; Ying Sun; Chuan-Ju Liu
Journal:  J Mol Med (Berl)       Date:  2018-10-20       Impact factor: 4.599

Review 5.  Neuroinflammation and blood-brain barrier disruption following traumatic brain injury: Pathophysiology and potential therapeutic targets.

Authors:  Suraj Sulhan; Kristopher A Lyon; Lee A Shapiro; Jason H Huang
Journal:  J Neurosci Res       Date:  2018-09-27       Impact factor: 4.164

Review 6.  Molecular regulations and therapeutic targets of Gaucher disease.

Authors:  Yuehong Chen; Neetu Sud; Aubryanna Hettinghouse; Chuan-Ju Liu
Journal:  Cytokine Growth Factor Rev       Date:  2018-04-11       Impact factor: 7.638

7.  Progranulin suppresses titanium particle induced inflammatory osteolysis by targeting TNFα signaling.

Authors:  Yun-peng Zhao; Jian-lu Wei; Qing-yun Tian; Alexander Tianxing Liu; Young-su Yi; Thomas A Einhorn; Chuan-ju Liu
Journal:  Sci Rep       Date:  2016-02-11       Impact factor: 4.379

Review 8.  Progranulin as a Potential Therapeutic Target in Immune-Mediated Diseases.

Authors:  Yue-Jiao Lan; Napoleon Bellua Sam; Ming-Han Cheng; Hai-Feng Pan; Jian Gao
Journal:  J Inflamm Res       Date:  2021-12-04

Review 9.  New discovery rarely runs smooth: an update on progranulin/TNFR interactions.

Authors:  Betty C Wang; Helen Liu; Ankoor Talwar; Jinlong Jian
Journal:  Protein Cell       Date:  2015-09-25       Impact factor: 14.870

10.  Chitinase-3-like Protein 1: A Progranulin Downstream Molecule and Potential Biomarker for Gaucher Disease.

Authors:  Jinlong Jian; Yuehong Chen; Rossella Liberti; Wenyu Fu; Wenhuo Hu; Rachel Saunders-Pullman; Gregory M Pastores; Ying Chen; Ying Sun; Gregory A Grabowski; Chuan-Ju Liu
Journal:  EBioMedicine       Date:  2018-01-31       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.